Skip to main content
Julia Biernot, MD, Neurology, Baltimore, MD

JuliaMariaBiernotMD

Neurology Baltimore, MD

Neurodegenerative, Dementia & Geriatrics

Physician

Dr. Biernot is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Biernot's full profile

Already have an account?

  • Office

    16 South Eutaw St
    Suite 300
    Baltimore, MD 21201
    Phone+1 410-328-4323

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Neuromuscular Medicine (Neurology), 2010 - 2011
  • University of Connecticut
    University of ConnecticutResidency, Neurology, 2007 - 2010
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 2006 - 2009
  • University of  Medicine  Sci In Poznan, Faculty Ii
    University of Medicine Sci In Poznan, Faculty IiClass of 2006

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2020 - 2026
  • IL State Medical License
    IL State Medical License 2013 - 2023
  • MI State Medical License
    MI State Medical License 2017 - 2018
  • PA State Medical License
    PA State Medical License 2011 - 2012
  • OH State Medical License
    OH State Medical License 2010 - 2011
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Publications & Presentations

PubMed

Press Mentions

  • Avoiding ‘Evidence-Biased’ Care: Challenges of Neurodegenerative Disease Focus Groups
    Avoiding ‘Evidence-Biased’ Care: Challenges of Neurodegenerative Disease Focus GroupsAugust 27th, 2021
  • New Alzheimer’s Drug Aducanumab: Cost, Side Effects, Timeline and Other Questions Answered
    New Alzheimer’s Drug Aducanumab: Cost, Side Effects, Timeline and Other Questions AnsweredJune 10th, 2021
  • The First Struggle for Most Dementia Patients Is Getting Diagnosed
    The First Struggle for Most Dementia Patients Is Getting DiagnosedSeptember 24th, 2019